P. Teo

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

Anthony T.�C. Chan, P. Teo, Roger K.C. Ngan et al. · Journal of Clinical Oncology · 2002 · 482 citations

High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.

Kwok Wai Lo, Joseph Kwong, Angela Bik‐Yu Hui et al. · PubMed · 2001 · 295 citations

Tumor Biology, Oncogenic Agent, Medicine +13

Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography

P. Teo, Peter S. Y. Yu, W. Y. Lee et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 214 citations

Adaptive Radiotherapy, Nondisseminated Nasopharyngeal Carcinoma, Health Sciences +12

High resolution allelotype of microdissected primary nasopharyngeal carcinoma.

Kwok Wai Lo, P. Teo, Angela Bik‐Yu Hui et al. · PubMed · 2000 · 165 citations

Tumor Biology, Allelic Variant, Tumoral Pathology +15

Clinical features and management of distant metastases of nasopharyngeal carcinoma.

S. F. Leung, P. Teo, W. Shiu et al. · PubMed · 1991 · 92 citations

Surgical Oncology, Health Sciences, Radiation Therapy +12